Ronald S. Black

7.4k total citations · 2 hit papers
46 papers, 3.3k citations indexed

About

Ronald S. Black is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Ronald S. Black has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 17 papers in Psychiatry and Mental health and 12 papers in Molecular Biology. Recurrent topics in Ronald S. Black's work include Alzheimer's disease research and treatments (23 papers), Dementia and Cognitive Impairment Research (14 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Ronald S. Black is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Dementia and Cognitive Impairment Research (14 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). Ronald S. Black collaborates with scholars based in United States, United Kingdom and Canada. Ronald S. Black's co-authors include Michael Grundman, Nick C. Fox, Martin N. Rossor, Lisa Jenkins, Reisa A. Sperling, Sue G. Griffith, Enchi Liu, H. Robert Brashear, S. Gilman and Martin Koller and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Annals of Neurology.

In The Last Decade

Ronald S. Black

44 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

2011 554 citations Reisa A. Sperling, Clifford R. Jack et al. Alzheimer s & Dementia profile →
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

2010 536 citations Juha O. Rinne, David J. Brooks et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald S. Black United States	22	2.4k	1.1k	715	686	609	46	3.3k
Marwan Sabbagh United States	9	1.9k 0.8×	1.2k 1.1×	687 1.0×	536 0.8×	731 1.2×	14	3.7k
Lutz Froelich Germany	19	1.9k 0.8×	1.4k 1.3×	658 0.9×	569 0.8×	777 1.3×	54	3.9k
Caroline E. Hope United States	7	2.0k 0.8×	504 0.5×	675 0.9×	460 0.7×	689 1.1×	8	2.5k
Michio Kanekiyo United States	12	1.8k 0.8×	1.1k 1.1×	538 0.8×	534 0.8×	707 1.2×	28	3.3k
Sergey Shcherbinin United States	23	1.9k 0.8×	1.1k 1.1×	462 0.6×	508 0.7×	617 1.0×	95	3.1k
H. Robert Brashear United States	30	1.5k 0.6×	906 0.9×	581 0.8×	555 0.8×	718 1.2×	86	3.8k
Vitaliy Ovod United States	19	2.9k 1.2×	1.5k 1.4×	950 1.3×	379 0.6×	940 1.5×	26	4.2k
Carl Sadowsky United States	29	1.6k 0.7×	1.7k 1.6×	465 0.7×	614 0.9×	336 0.6×	67	3.2k
Tobias Bittner Switzerland	26	2.5k 1.1×	1.6k 1.5×	1.0k 1.5×	333 0.5×	882 1.4×	56	3.8k
Tom Kasten United States	15	2.2k 0.9×	606 0.6×	765 1.1×	348 0.5×	846 1.4×	19	3.3k

Countries citing papers authored by Ronald S. Black

Since Specialization

Citations

This map shows the geographic impact of Ronald S. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald S. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald S. Black more than expected).

Fields of papers citing papers by Ronald S. Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald S. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald S. Black. The network helps show where Ronald S. Black may publish in the future.

Co-authorship network of co-authors of Ronald S. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald S. Black. A scholar is included among the top collaborators of Ronald S. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald S. Black. Ronald S. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ivanoiu, Adrian, Jérémie Pariente, Kevin Booth, et al.. (2016). Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies. Alzheimer s Research & Therapy. 8(1). 24–24. 33 indexed citations

Harrison, John, Dorene M. Rentz, Trent McLaughlin, et al.. (2014). Cognition in MCI and Alzheimer’s Disease: Baseline Data from a Longitudinal Study of the NTB. The Clinical Neuropsychologist. 28(2). 252–268. 10 indexed citations

Sperling, Reisa A., Stephen Salloway, David J. Brooks, et al.. (2012). Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. The Lancet Neurology. 11(3). 241–249. 366 indexed citations

Sperling, Reisa A., Clifford R. Jack, Sandra E. Black, et al.. (2011). Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimer s & Dementia. 7(4). 367–385. 554 indexed citations breakdown →

Rinne, Juha O., David J. Brooks, Martin N. Rossor, et al.. (2010). 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. The Lancet Neurology. 9(4). 363–372. 536 indexed citations breakdown →

Blennow, Kaj, Henrik Zetterberg, Jenny Wei, et al.. (2010). O3‐05‐01: Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_4). 10 indexed citations

Black, Ronald S., Reisa A. Sperling, Beth Safirstein, et al.. (2010). A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease. Alzheimer Disease & Associated Disorders. 24(2). 198–203. 136 indexed citations

Black, Ronald S., Barry Greenberg, J. Michael Ryan, et al.. (2009). Scales as outcome measures for Alzheimer's disease. Alzheimer s & Dementia. 5(4). 324–339. 32 indexed citations

Grundman, Michael, et al.. (2008). P3‐137: The neuropsychological test battery discriminates patients with mild cognitive impairment from normal controls and Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_17). 1 indexed citations

10.

Ridha, Basil H., Valerie Anderson, Josephine Barnes, et al.. (2008). Volumetric MRI and cognitive measures in Alzheimer disease. Journal of Neurology. 255(4). 567–574. 103 indexed citations

11.

Harrison, John, Sonia L. Minassian, Lisa Jenkins, et al.. (2007). A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials. Archives of Neurology. 64(9). 1323–1323. 156 indexed citations

12.

Lee, Michael, Frédérique Bard, Kelly Johnson‐Wood, et al.. (2005). Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies. Annals of Neurology. 58(3). 430–435. 107 indexed citations

13.

Black, Ronald S., et al.. (1994). Expression of Neuronal Proteins in Cells from Normal Adult Rat Brain Propagated in Serial Culture. Journal of Neurochemistry. 62(6). 2132–2140. 6 indexed citations

14.

Kurita, Akira, John P. Blass, Karen A. Nolan, Ronald S. Black, & Howard T. Thaler. (1993). Relationship between Cognitive Status and Behavioral Symptoms in Alzheimer's Disease and Mixed Dementia. Journal of the American Geriatrics Society. 41(7). 732–736. 24 indexed citations

15.

Black, Ronald S., et al.. (1992). Pentoxifylline in Cerebrovascular Dementia. Journal of the American Geriatrics Society. 40(3). 237–244. 52 indexed citations

16.

Black, Ronald S., et al.. (1992). Presence of typical neuronal markers in serially cultured cells from adult human brain. Journal of the Neurological Sciences. 111(1). 104–112. 11 indexed citations

17.

Blass, John P., Karen A. Nolan, Ronald S. Black, & Akira Kurita. (1991). Delirium: Phenomenology and Diagnosis—A Neurobiologie View. International Psychogeriatrics. 3(2). 121–134. 16 indexed citations

18.

Chang, Esther H., et al.. (1987). Interferon- Induces Altered Oncogene Expression and Terminal Differentiation in A431 Cells. Experimental Biology and Medicine. 186(3). 319–326. 21 indexed citations

19.

Black, Ronald S. & Robert G. Robinson. (1985). Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity. Pharmacology Biochemistry and Behavior. 22(2). 327–331. 7 indexed citations

20.

Black, Ronald S., et al.. (1979). Influence of silver, mercury, lead, cadmium, and selenium on glutathione peroxidase and transferase activities in rats. Biological Trace Element Research. 1(4). 313–324. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact